Process Evaluation of a Double‐Blind Randomized Controlled Trial to Assess the Efficacy and Safety of a Quadruple Ultra‐Low‐Dose Treatment for Hypertension Within a Federally Qualified Health Center Network (QUARTET USA)

Process Evaluation of a Double‐Blind Randomized Controlled Trial to Assess the Efficacy and Safety of a Quadruple Ultra‐Low‐Dose Treatment for Hypertension Within a Federally Qualified Health Center Network (QUARTET USA)

Background This convergent parallel‐design mixed‐methods process evaluation of the QUARTET USA (Quadruple Ultra‐Low‐Dose Treatment for Hypertension USA) clinical trial (NCT03640312) explores patient and health care professional perceptions about the use of low‐dose quadruple therapy (LDQT) as a nove...

Full description

Bibliographic Details
Main Authors: Olutobi A. Sanuade, Tyler A. Jacobson, Adriana Quintana, Fallon M. Flowers, Hiba Abbasi, My H. Vu, Abigail S. Baldridge, Jairo Mejia, Danielle Lazar, Jody D. Ciolino, Mark D. Huffman, Namratha R. Kandula
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
fixed‐dose combination therapy
hypertension
low‐dose quadruple therapy
qualitative research
QUARTET USA (Quadruple Ultra‐Low‐Dose Treatment for Hypertension USA) clinical trial
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.123.032236

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.123.032236

Similar Items